Quest Diagnostics (DGX) – Business Wire
-
Quest Diagnostics and Ultima Collaborate to Scale Ultima’s Technology in Fast-Growing Minimal Residual Disease and Whole Genome Sequencing
-
Cleveland Diagnostics Announces Agreement with Quest Diagnostics to Expand Patient Access to IsoPSA® Prostate Cancer Testing
-
Agilent to Collaborate with Quest Diagnostics to Extend Access to the Agilent Resolution ctDx FIRST Liquid Biopsy Test
-
DermTech and Sonora Quest Laboratories Expand Access to Innovative Melanoma Detection Test
-
Achievers and Quest Diagnostics Win Gold in the 2022 Brandon Hall Group Excellence Technology Awards
-
Paige Announces Partnership with Sonora Quest Laboratories to Accelerate Precision Diagnostics for Patients Across Arizona
-
Rite Aid and Quest Diagnostics Expand Access to COVID-19 PCR Testing Nationwide
-
Siemens Healthineers Launches Enhanced Liver Fibrosis (ELF) Test in the U.S.
-
Biocept to Collaborate with Quest Diagnostics to Provide Advanced NGS-Based Liquid Biopsy Testing for Patients with Lung Cancer
-
Epizyme Launches EZH2Now Testing Program with Quest Diagnostics for Relapsed or Refractory Follicular Lymphoma Patients
-
WNS Announces Addition of Tim Main to Board of Directors
-
CIC Health and Quest Diagnostics Collaborate to Help Schools, Camps Open Safely Nationwide
-
IQVIA Acquires Remaining Interest in Q² Solutions from Quest Diagnostics; Raises Full Year 2021 Adjusted Diluted EPS Guidance
-
GRAIL and Quest Diagnostics Announce Collaboration to Support Galleri, First-of-Kind Multi-Cancer Early Detection Blood Test
-
Ancestry® Launches AncestryHealth® Powered by Next Generation Sequencing (NGS)
-
Verily Announces New Customers and Partners for its Healthy at Work Program
-
Siemens Healthineers Wins Bid to Become Primary Supplier for Quest Diagnostics Immunoassay Testing with Atellica Solution
-
Enzo Biochem Responds to Series of Misleading and Inaccurate Statements from Activist Hedge Fund Harbert
Back to DGX Stock Lookup
